Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations in Lung Adenocarcinoma.
Lohinai Z, Hoda MA, Fabian K, Ostoros G, Raso E, Barbai T, Timar J, Kovalszky I, Cserepes M, Rozsas A, Laszlo V, Grusch M, Berger W, Klepetko W, Moldvay J, Dome B, Hegedus B.
Lohinai Z, et al. Among authors: cserepes m.
J Thorac Oncol. 2015 May;10(5):738-746. doi: 10.1097/JTO.0000000000000492.
J Thorac Oncol. 2015.
PMID: 25664625
Free article.